다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK) 뉴스

STOK

Stoke Therapeutics (STOK)

Stoke Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:STOK

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/06	05:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/06/04	05:30	Business Wire	Stoke Therapeutics to Present at Upcoming Investor Conferences in June	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/23	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/23	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/21	05:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/21	05:21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/18	05:30	Business Wire	Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/18	05:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/18	05:12	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/07	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/06	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STOK	Stoke Therapeutics Inc
2024/05/06	20:00	Business Wire	Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates	NASDAQ:STOK	Stoke Therapeutics Inc
2024/04/29	21:00	Business Wire	Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer	NASDAQ:STOK	Stoke Therapeutics Inc
2024/04/17	21:00	Business Wire	Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	NASDAQ:STOK	Stoke Therapeutics Inc
2024/04/05	05:30	Business Wire	Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/28	12:40	Business Wire	Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/27	05:07	Business Wire	Stoke Therapeutics Announces Proposed Public Offering	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/26	05:01	Business Wire	Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/26	05:01	Business Wire	Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/06	06:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/03/02	06:28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/27	00:38	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/27	00:36	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/14	23:20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/06	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/02/02	06:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/18	06:30	Business Wire	Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/08	22:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/08	22:00	Business Wire	Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024	NASDAQ:STOK	Stoke Therapeutics Inc
2024/01/05	06:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STOK	Stoke Therapeutics Inc

검색 관련기사 보기:NASDAQ:STOK

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

Bank of America

Energy Select Sector SPDR

Health Care Select Sector

JP Morgan Chase

US Dollar vs Euro

Deutsche Telekom (QX)

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관